Atara Biotherapeutics (ATRA) Interest & Investment Income (2013 - 2026)
Atara Biotherapeutics (ATRA) posted Interest & Investment Income of -$1000.0 for Q1 2026, little changed on a QoQ basis from -$1000.0 in Q4 2025, and up 87.5% year-over-year from -$533.33 in Q1 2025.
Atara Biotherapeutics (ATRA) Interest & Investment Income (2013 - 2026) Analysis & Trends
Atara Biotherapeutics' Interest & Investment Income history runs 14 years deep, the most recent figure standing at -$1000.0 for Q1 2026.
- Quarterly Interest & Investment Income rose 87.5% year-over-year to -$1000.0 in Q1 2026, while the trailing twelve-month figure through Dec 2025 was -$7000.0 (down 103.3% YoY) and the FY2025 annual result came in at -$7000.0, down 103.3% from the prior year.
- Interest & Investment Income was -$1000.0 for Q1 2026 at Atara Biotherapeutics, roughly flat from -$1000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $892000.0 in Q4 2022 and bottomed at -$1.5 million in Q1 2022.
- A 5-year average of $23000.0 and a median of $19000.0 in 2024 frame the typical range for Interest & Investment Income.
- Peak annual rise in Interest & Investment Income reached 327.55% in 2022, while the deepest fall reached 1028.89% in 2022.
- Atara Biotherapeutics' Interest & Investment Income stood at $892000.0 in 2022, then sank by 58.86% to $367000.0 in 2023, then slumped by 103.81% to -$14000.0 in 2024, then jumped by 92.86% to -$1000.0 in 2025, then changed by 0.0% to -$1000.0 in 2026.
- Business Quant data shows ATRA's Interest & Investment Income at -$1000.0 in Q1 2026, -$1000.0 in Q4 2025, and $2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | -1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Mar 31, 2025 | -8,000.00 |
| Dec 31, 2024 | -14,000.00 |
| Sep 30, 2024 | 36,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Mar 31, 2024 | 149,000.00 |
| Dec 31, 2023 | 367,000.00 |
| Sep 30, 2023 | 362,000.00 |
| Jun 30, 2023 | 304,000.00 |
| Mar 31, 2023 | 830,000.00 |
| Dec 31, 2022 | 892,000.00 |
| Sep 30, 2022 | -341,000.00 |
| Jun 30, 2022 | -726,000.00 |
| Mar 31, 2022 | -1.52 Mn |
| Dec 31, 2021 | -392,000.00 |
| Sep 30, 2021 | -38,000.00 |
| Jun 30, 2021 | -99,000.00 |
| Mar 31, 2021 | -135,000.00 |